Genmab's Phase 3 LiGeR-HN1 trial found that petosemtamab combined with pembrolizumab significantly improved overall survival by reducing death risk by 50% in patients with PD-L1 positive recurrent/metastatic head and neck squamous cell carcinoma, regardless of HPV status. The combination also showed a higher objective response rate and was well tolerated with no new safety concerns. These results mark a potential new first-line treatment option for this hard-to-treat cancer, and Genmab plans to engage global regulators and present full data at a future medical meeting.
Genmab's announcement on petosemtamab combination trial results provides context for readers interested in health-sector stocks. For readers following this sector, here is Pluang's market snapshot as of Oct 28, 2026 19:43 WIB: out of 150 priced US health stocks, 44 rose and 95 fell. Among notable movers, Aurora Cannabis Inc (ACB) gained 6.99% to USD 4.44, GE HealthCare Technologies Inc (GEHC) rose 5.47% to USD 75.00, while BioNano Genomics Inc (BNGO) declined 8.20% to USD 1.12 with a typical hold time of 51 days on Pluang.
Arcutis Biotherapeutics has appointed Dr. Rob Scott, a seasoned pharmaceutical executive with over 40 years of experience, to its Board of Directors. Dr. Scott's expertise in developing and securing approvals for innovative medicines, including derma...
Air Canada and CAE announced the opening of applications on November 1, 2026, for the 2027 Commandante-Judy-Cameron scholarships. These scholarships support up to eight Canadian women pursuing professional pilot or aircraft maintenance technician tra...
The Legacy Lab by Team One released its 2026 Legacy Makers 100 list, identifying brands consumers trust to have their best interests at heart and remain relevant long-term. St. Jude Children's Research Hospital topped the list for the second year. Th...
Circuit Mind has introduced AVE (Agentic Verification Engine), an AI-powered application that verifies printed circuit board (PCB) schematics against datasheets and internal design rules to catch errors early and avoid expensive respins. AVE compleme...
Grabar Law Office is investigating claims against officers and directors of Erasca, Planet Fitness, PROCEPT BioRobotics, and The Simply Good Foods Company for alleged breaches of fiduciary duties. The investigations focus on misleading statements and...
